Skip to content

Prognosis and Treatment of COPD in Primary Care-use of Biomarkers

Prognosis and Treatment of COPD in Primary Care-use of Biomarkers

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01698151
Acronym
PROTECCT-M
Enrollment
2000
Registered
2012-10-02
Start date
2012-10-31
Completion date
2018-12-31
Last updated
2016-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Keywords

Chronic obstructive Pulmonary Disease, COPD

Brief summary

This is an observational study in primary care aiming to validate biomarkers for chronic obstructive pulmonary disease (COPD).

Interventions

None listed

Sponsors

The Ministry of Science, Technology and Innovation, Denmark
CollaboratorOTHER_GOV
Region of Southern Denmark
CollaboratorOTHER
University of Southern Denmark
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* 40 years old or more, * diagnosis of COPD in primary care

Exclusion criteria

* Major psychiatric illness, * inability to visit primary care doctor, * inability to understand danish language,

Design outcomes

Primary

MeasureTime frame
HospitalizationDecember 1, 2015

Countries

Denmark

Contacts

Primary ContactFrans Boch Waldorff, MD, PhD
fwaldorff@health.sdu.dk+45 6550 7643
Backup ContactHelle Reintoft Andersen
hereandersen@health.sdu.dk+45 6550 3830

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026